Risk factors and outcomes of carbapenem-resistant acinetobacter baumannii bacteremia in neonatal intensive care unit: A case-case-control study

Pediatric Infectious Disease Journal

Volumn 32, Issue 2, 2013, Pages 140-145

  Thatrimontrichai, Anucha ^a   Apisarnthanarak, Anucha ^b   Chanvitan, Prasin ^a   Janjindamai, Waricha ^a   Dissaneevate, Supaporn ^a   Maneenil, Gunlawadee ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

Author keywords

Acinetobacter baumannii; carbapenems; drug resistance; neonatal intensive care units; newborn

Indexed keywords

AMPICILLIN; CARBAPENEM; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; IMIPENEM; PENICILLIN DERIVATIVE; SULBACTAM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; BIRTH WEIGHT; BLOOD CELL COUNT; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; INFECTION CONTROL; LEUKOPENIA; MEDICAL RECORD REVIEW; MORTALITY; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPTIC SHOCK; TOTAL PARENTERAL NUTRITION; UMBILICAL ARTERY CATHETER;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; ODDS RATIO; RISK FACTORS; STATISTICS, NONPARAMETRIC; THAILAND; TREATMENT OUTCOME;

EID: 84873057572     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318270b108     Document Type: Review

References (34)

1. Giamarellou H, Antoniadou A, Kanellakopoulou K. Acinetobacter bau-mannii: a universal threat to public health? Int J Antimicrob Agents. 2008;32:106-119.
2. Luvira V. Overveiw of antibiotic resistance. Songkla Med J. 2006;24:453-459.
3. National Antimicrobial Resistance Surveillance Center Thailand. Percent Susceptibility. 2012. Available at: http://narst.dmsc.moph.go.th/. Accessed April 15, 2012.
4. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imi-penem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai. 2009;92:413-419.
5. Apisarnthanarak A, Mundy LM. Mortality associated with Pandrug-resist-ant Acinetobacter baumannii infections in Thailand. Am J Infect Control. 2009;37:519-520.
6. Al Jarousha AM, El Jadba AH, Al Aff AS, et al. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Int J Infect Dis. 2009;13:623-628.
7. Bas AY, Demirel N, Zenciroglu A, et al. Nosocomial blood stream infections in a neonatal intensive care unit in Ankara, Turkey. Turk J Pediatr. 2010;52:464-470.
8. Wu JH, Chen CY, Tsao PN, et al. Neonatal sepsis: a 6-year analysis in a neonatal care unit in Taiwan. Pediatr Neonatol. 2009;50:88-95.
9. Zakariya B P, Bhat V, Harish BN, et al. Neonatal sepsis in a tertiary care hospital in South India: bacteriological profle and antibiotic sensitivity pattern. Indian J Pediatr. 2011;78:413-417.
10. Bhat YR, Lewis LE, K E V. Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India. Ital J Pediatr. 2011;37:32.
11. Litzow JM, Gill CJ, Mantaring JB, et al. High frequency of multidrug-resist-ant gram-negative rods in 2 neonatal intensive care units in the Philippines. Infect Control Hosp Epidemiol. 2009;30:543-549.
12. Roy S, Basu S, Dasgupta S, et al. Carbapenem resistance in Acinetobacter baumannii isolated from blood of neonates with sepsis. Indian J Med Micro-biol. 2010;28:416-417.
13. McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation of Acinetobac-ter infections: 1987-1996. Nosocomial Infections Surveillance System. Clin Infect Dis. 1999;29:1133-1137.
14. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358:1271-1281.
15. Thamlikitkul V, Santiprasitkul S, Suntanondra L, et al. Skin fora of patients in Thailand. Am J Infect Control. 2003;31:80-84.
16. Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006-1015.
17. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance defnition of health care-associated infection and criteria for specifc types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
18. Parry G, Tucker J, Tarnow-Mordi W; UK Neonatal Staffng Study Collaborative Group. CRIB II: an update of the clinical risk index for babies score. Lancet. 2003;361:1789-1791.
19. Centers for Disease Control and Prevention. Central Line-Associated Bloodstream Infection (CLABSI) Event. 2011. Available at: http://www.cdc.gov/ nhsn/PDFs/pscManual/4PSC-CLABScurrent.pdf. Accessed January 1, 2012.
20. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: defni-tions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
21. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, et al. Antimicrobial use and the infuence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25:735-741.
22. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31(suppl 4):S131-S138.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement (CLSI document M100-S21). Wayne, PA: Clinical and Laboratory Standards Institute; 2011.
24. Magiorakos A P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard defnitions for acquired resistance. Clin Microbiol Infect. 2012;18:268-281.
25. Routsi C, Pratikaki M, Platsouka E, et al. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection. 2010;38:173-180.
26. Song JY, Cheong HJ, Choi WS, et al. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. J Med Microbiol. 2011;60(pt 5):605-611.
27. Huang ST, Chiang MC, Kuo SC, et al. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect. 2012;45:356-362.
28. Kim YJ, Kim SI, Hong KW, et al. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci. 2012;27:471-475.
29. Zhang TQ, Dong L, Wang ZY, et al. Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children. Zhonghua Er Ke Za Zhi. 2011;49:545-549.
30. Katragkou A, Kotsiou M, Antachopoulos C, et al. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study. Intensive Care Med. 2006;32:1384-1391.
31. McGrath EJ, Chopra T, Abdel-Haq N, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol. 2011;32:34-41.
32. Kaye KS, Harris AD, Samore M, et al. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol. 2005;26:346-351.
33. Sheng WH, Liao CH, Lauderdale TL, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis. 2010;14:e764-e769.
34. Apisarnthanarak A, Kiratisin P, Saifon P, et al. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-produc-ing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007;35:606-612.